N40.0
Benign prostatic hyperplasia without lower urinary tract symptoms
Clinical Classification Guidelines
Inclusion Terms
- Enlarged prostate without LUTS
- Enlarged prostate NOS
Medical Intelligence & Overview
Benign prostatic hyperplasia (BPH) is a common condition affecting many men as they age, characterized by an enlarged prostate gland. When this enlargement occurs without causing symptoms related to the lower urinary tract, it is classified under ICD-10 code N40.0. This condition, often called asymptomatic BPH, involves prostate growth that doesn’t immediately interfere with urination, making it distinct from other types of prostate enlargement that cause bothersome symptoms. Keep reading to learn more about the causes, potential symptoms, diagnosis, and management options of this condition.
Causes & Symptoms
Clinical Causes: Age-related hormonal changes, particularly involving testosterone and dihydrotestosterone (DHT) Genetic predisposition leading to prostate tissue growth Family history of prostate issues Lifestyle factors such as obesity, poor diet, and lack of physical activity can influence prostate health Possible inflammatory processes within the prostate tissue, although not fully understood
Key Symptoms: Typically no urinary symptoms are present, which is why it is called asymptomatic BPH In cases where symptoms may appear later, these can include increased frequency of urination Nocturia, or needing to urinate frequently during the night Weak urinary stream or difficulty starting urination Feeling of incomplete bladder emptying
Diagnostic & Treatment
Diagnosis Path: Diagnosis of asymptomatic BPH is often incidental, identified through routine health examinations or imaging studies. Common approaches include: - Digital rectal examination (DRE) to assess prostate size and texture - Ultrasound imaging to visualize prostate enlargement - Prostate-specific antigen (PSA) blood test to evaluate prostate health (though PSA levels can be normal in asymptomatic cases) - Urinalysis to rule out infections or other urinary conditions - Prostate biopsy may be considered if there are concerns about other prostate diseases, such as prostate cancer
Treatment Protocols: In cases where the prostate enlargement does not cause symptoms or complications, active surveillance may be recommended, involving regular monitoring. If intervention becomes necessary due to future development of symptoms or complications, options include: - Medications such as alpha-blockers to relax prostate muscles and improve urine flow - 5-alpha-reductase inhibitors to reduce prostate size - Minimally invasive procedures or surgery, such as transurethral resection of the prostate (TURP), if urinary symptoms develop or complications occur - Lifestyle modifications, including maintaining a healthy weight, engaging in regular exercise, and avoiding bladder irritants like caffeine and alcohol
Clinical Advice & FAQs
Billing Guidance
Is N40.0 a billable ICD-10 code?
Yes, N40.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N40.0?
Clinical documentation must specify the nature of Benign prostatic hyperplasia without lower urinary tract symptoms and any associated comorbidities for accurate reporting.
Cite this Clinical Reference